Search

everythinglearnresearchcommunity

for

Search:↓

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Flutamide reduces hair growth better but has more side effects.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.